Acupuncture for Anxiety/Depression in Patients With Breast Cancer
Effects of Acupuncture for Anxiety and/or Depression Among Patients With Breast Cancer
1 other identifier
interventional
360
1 country
1
Brief Summary
The aim of this study is to evaluate the effects and safety of acupuncture on anxiety and/or depression among patients with breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 14, 2025
CompletedStudy Start
First participant enrolled
September 15, 2025
CompletedFirst Posted
Study publicly available on registry
September 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
September 24, 2025
September 1, 2025
12 months
September 14, 2025
September 19, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The change from baseline in the total score of Hospital Anxiety and Depression Scale (HADS).
The total score of HADS ranges from 0 to 42, with higher scores indicating greater anxiety and depression.
week 8
Secondary Outcomes (11)
The change from baseline in the total score of HADS.
weeks 4, 12, 16 and 20
The change from baseline in the score of HADS-A and HADS-D
weeks 4, 8, 12, 16 and 20
Proportion of participants with a total HADS score less than 15, an HADS-A score of less than or equal to 7, and an HADS-D score of less than or equal to 7
weeks 4, 8, 12, 16 and 20
Change from baseline in Hamilton Depression Scale-14
Week 4, 8 and 20
Change from baseline in Hamilton Depression Scale-17
Week 4, 8 and 20
- +6 more secondary outcomes
Other Outcomes (6)
Expectance assessment
baseline
Assessment of belief in acupuncture
baseline and week 8
Blinding assessment
week 8
- +3 more other outcomes
Study Arms (2)
Electroacupuncture group
EXPERIMENTALAcupoints:Bai Hui acupoint, An Mian acupoint, Shang Yin Tang acupoint, Tai Yang acupoint, Tian Shu acupoint, Zu SanLi acupoint, Tai Chong acupoint, Shen Men acupoint.
Sham electroacupuncture (SEA) group
SHAM COMPARATORAcupoints: Bai Hui acupoint, An Mian acupoint, Shang Yin Tang acupoint, Tai Yang acupoint, Tian Shu acupoint, Zu San Li acupoint, Tai Chong acupoint, Shen Men acupoint.
Interventions
The needles will be inserted to 15-40mm in acupoints through adhesive pads. Needles will be lifted, thrusted and twirled gently for 3 times to achieve deqi sensation and manipulated every ten minutes during 30-minute maintenance. The electronic acupuncture apparatus will be connected to the bileteral Taiyang, Anmian and Baihui, with a continuous wave of 2 Hertz (Hz) and an electric current of 1-3 milliampere (mA). Participants receive acupuncture treatment three times a week in the first two weeks and twice a week in the last six weeks.
The needle will be inserted to 2-3mm in Bai Hui acupoint. For the remaining acupoints, needles will be inserted into the pad till reaching but without penetrating the skin. Needles will be lifted, thrusted and twirled gently for 3 times to simulate the effects of the needle tip penetrating the skin. The electronic acupuncture apparatus will be connected to the Baihui acupoint, Shang Yin Tang acupoint, and bilateral An Mian acupoints, with a continuous wave of 2 Hertz (Hz) and an electric current of 0.1-0.3 mA. In about 3-5 seconds, the electric current will be turned down. Participants receive acupuncture treatment three times a week in the first two weeks and twice a week in the last six weeks.
Eligibility Criteria
You may qualify if:
- Female, aged 18 to 70 years old;
- Meeting the diagnostic criteria for breast cancer and at TMN I-III;
- Having completed specialized active treatment for at least one month;
- With an ECOG score of 0-2;
- Mild to moderate anxiety and/or depression;
- Voluntarily joining this study and signing the informed consent form.
You may not qualify if:
- Starting to take or change the regimen of anti-anxiety and/or -depression disorder medication within one month before enrolment;
- Received psychological intervention or physical therapy one month before enrolment or planning to use in the next 5 months;
- With diagnosis of anxiety and/or depression disorder prior to the diagnosis of breast cancer;
- Patients with suicidal tendencies, bipolar disorder and psychotic symptoms;
- Patients with severe anxiety and/or depression;
- Patients received acupuncture treatment within one month before enrolment;
- Participating in other clinical studies on the treatment of anxiety and/or depression;
- Combined with severe underlying diseases;
- Patients with severe skin ulcers;
- Pregnant or lactating patients;
- Poor compliance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Beijing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending physician
Study Record Dates
First Submitted
September 14, 2025
First Posted
September 19, 2025
Study Start
September 15, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
September 24, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- The data will be available with publication until until six months after publication.
- Access Criteria
- Formal request should be sent to puzhisun@163.com with a methodologically sound proposal. Researchers whose proposal has been approved. Researchers whose proposal has been approved will sign a data access agreement.
Deidentified participant data and data dictionary will be available with publication until six months after publication. Formal request should be sent to puzhisun@163.com with a methodologically sound proposal. Researchers whose proposal has been approved will sign a data access agreement.